glp 1 functional medicine How to Use GLP-1s the Way GLP-1 receptor agonists | How

This article examines tirzepatide's mechanism, approved uses, preliminary evidence on immune function, and established treatment options for autoimmune diseases

Individuals with type 2 diabetes typically experience an impaired incretin effect, though GLP-1 secretion itself may be normal, slightly reduced, or context-dependent

GLP-1 Success A better GLP-1 journey starts here *Eligible patients lost an average of 21% of their body weight (-48 lbs) in a 72-week clinical trial evaluating 15 mg tirzepatide, when paired with diet and exercise

Under condition of insulin resistance, SIRT1 expression is downregulated

[DOI] [PubMed] [Google Scholar] 108.Davies M, Faerch L, Jeppesen OK, et al